Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 21, 1997

View Archived Issues

Relaxin-like factor and relaxin analogues described

Novel rapamycin derivatives reported by Novartis

Alcon describes dihydropyridines for ocular use

Fibrinogen antagonists from Glaxo Wellcome

Sanofi Winthrop reveals calpain inhibitors

Novel vasopressin antagonists from Fujisawa

Novel anti-HIV agent reported by Belgian and Mauritian researchers

Antisense compound for asthma shows promise

Alpha-Beta/MycoTox antifungal collaboration

ARIAD and Genovo form gene therapy joint venture

Seragen begins to restructure, sells manufacturing/clinical operations facility

Immunex clones and describes target for RA

National Patent/PolyMASC extend cancer vaccine collaboration

MAA filed for Agouron anti-HIV drug

Cylexin enters clinical trials in newborns

Transdermal buspirone pivotal trials

Antiadhesion product enters clinical trials

Oncogen Science stock changes hands

Multinational clinical trial results for Zenapax

Centocor seeks expansion of ReoPro indications

Deltibant in SIRS

Positive clinical results for doxazosin as BPH Rx

Comparative trial of dorzolamide and acetazolamide

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...